/

VRPX

Virpax Pharmaceuticals, Inc.Closed

0.0002000.00 0.00%USD

OTC Markets OTCPK · as of Oct 12, 16:00 ET · 15m delay

Open

0.0210

Prev close

0.000200

Day range

0.02100.0210

52-week range

0.0001000.1000

Volume

510.17×

Mkt cap

248

P/E ttm

—

Fwd P/E

-0.00

EPS ttm

-1.28

Div yield

0.00%

Earnings

—

From 52w high

−99.80%

Price Chart

Yahoo Finance · delayed

VRPXOct 12, 2026O 0.0002H 0.0002L 0.0002C 0.00020.0000 (0.00%)

SMA 500.0034
SMA 2000.0057

1Y change −99.05% since Oct 10, 2025 close538 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

VRPX Virpax Pharmaceuticals, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −98.20%
1 month: +100.00%
3 months: −98.20%
6 months: −60.00%
Year to date: −98.20%
1 year: −99.05%

Valuation & ownership

Market cap: 248
Enterprise value: −1.51M
P/E (ttm): —
Forward P/E: -0.00
PEG ratio: —
Price / book: —
Price / sales (ttm): —
EV / EBITDA: —
EPS (ttm): -1.28
EPS (forward): -0.9000
Beta (5y monthly): -213.04
Dividend yield: 0.00%
Payout ratio: —
Shares outstanding: 1.24M
Float: 1.06M
Short % of float: 25.74%
Short ratio (days): 0.59
Held by insiders: 0.00%
Held by institutions: 0.00%
Avg volume (3m): 295
50-day average: 0.003420
200-day average: 0.005566
52-week change: −99.05%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): oversold 24.8
vs 50-day SMA: −94.15%
vs 200-day SMA: −96.51%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 1055.34%
Realised vol (20d, ann.): 2253.5%
From 52-week high: −99.80%
From 52-week low: +100.00%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): —
Revenue growth (yoy): —
Earnings growth (yoy): —
Gross margin: 0.00%
Operating margin: 0.00%
Profit margin: 0.00%

DES

About Virpax Pharmaceuticals, Inc.

Yahoo Finance profile

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also include AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.

Sector: Healthcare
Industry: Biotechnology
Employees: 2
Headquarters: Berwyn, PA, United States
Website: virpaxpharma.com
Officers: Mr. Jatinder Dhaliwal Interim CFO, CEO & Director
Dr. Sheila A. Mathias J.D., M.B.A., Ph.D. Chief Scientific Officer

SEAS

Seasonality · VRPX

2021–2026 · monthly returns

Strongest month Aug +55.42%Weakest month Apr −32.32%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	0.0	-3.6	-96.3	25.0	-80.0	11000.0	-99.1	0.0	11000.0	-98.2			−98.2%
2025	-17.8	-23.1	-80.0	-78.3	-5.6	28.7	-96.5	0.9	216.2	-40.2	0.0	-47.1	−99.9%
2024	3.1	-7.5	39.6	-37.8	-73.6	-26.1	135.8	-33.2	-14.8	5.6	-37.1	-17.6	−88.1%
2023	59.1	-4.7	-16.7	-9.5	10.5	37.6	-17.6	-3.4	-7.0	-6.9	-46.3	-19.9	−48.6%
2022	-37.9	1.9	2.3	-20.3	-19.8	18.3	-9.5	-16.4	-6.3	-10.1	-21.5	-25.9	−81.9%
2021			-12.6	-15.7	8.6	5.6	-2.2	329.2	-74.9	-12.9	12.0	-26.7	−36.4%

VRPX

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

VRPX

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Virpax Pharmaceuticals, Inc.

Seasonality · VRPX

Insider Activity · VRPX

Congress Trades · VRPX

Investors Holding VRPX

Investors Holding VRPX

Congress Trades · VRPX

Insider Activity · VRPX

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Virpax Pharmaceuticals, Inc.

Earnings & Dividends

News

Seasonality · VRPX